Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.870
-0.030 (-1.03%)
At close: Jun 26, 2026, 4:00 PM EDT
3.130
+0.260 (9.06%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending March 31, 2026. In the year 2025, Genelux had annual revenue of $8.00K.
Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
15,876.19
Revenue / Employee
$308
Employees
26
Market Cap
127.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.00K | - | - |
| Dec 31, 2024 | 8.00K | -162.00K | -95.29% |
| Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
| Dec 31, 2022 | 11.07M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| Spero Therapeutics | 61.19M |
| Pyxis Oncology | 13.86M |
| Coya Therapeutics | 7.94M |
| NRx Pharmaceuticals | 2.29M |
| Connect Biopharma Holdings | 233.00K |
| NeOnc Technologies Holdings | 39.99K |
| Fractyl Health | 3.00K |
GNLX News
- 10 days ago - Genelux Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Genelux reports Q1 EPS (20c), consensus (19c) - TheFly
- 7 weeks ago - Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Genelux Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Genelux Earnings release: Q1 2026 - Filings
- 7 weeks ago - Genelux Slides: Corporate presentation - Filings
- 2 months ago - Genelux Proxy statement: Proxy filing - Filings
- 2 months ago - Genelux Proxy statement: Proxy filing - Filings